by FiveSenses | Jun 6, 2023 | News Release
Vancouver, BC, Canada, June 6, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce that it mandated... 
by Defence Therapeutics | May 30, 2023 | News Release
Vancouver, BC, Canada, May 26th, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that, in... 
by FiveSenses | May 24, 2023 | News Release
Vancouver, BC, Canada, May 24th 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce the successful... 
by FiveSenses | May 2, 2023 | News Release
Vancouver, BC, Canada, May 2nd, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immuneoncology vaccines and drug delivery technologies is please to announce the successful... 
by FiveSenses | Apr 27, 2023 | News Release
Vancouver, BC, Canada, April 27, 2023 – Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that the United States Patent...
Recent Comments